Current investigations into retatrutide, a dual agonist for GLP-1 and GIP receptors, are demonstrating encouraging effects in managing excess mass and type 2 disease. Animal evidence suggest a unique process https://shopretatrutidepeptide.com/2026/03/12/what-is-retatrutide-peptide/